Creating awareness about prevalence and variation
The rare are many. Experts estimate that up to 250 new rare diseases are discovered every year. These diseases reveal the processes that take place in the human body and the tiny adjustments that can make the difference between health and disease. This knowledge can save the lives, and ultimately benefits everyone, because research into rare diseases can help revolutionize the “medicine of tomorrow”.
What are rare diseases?
Rare diseases, also known as orphan diseases, are classified as such in many countries when they affect no more than 1 in 2,000 to 1 in 5,000 people. This can vary depending on the region or healthcare system. In the EU, a disease is considered “rare” if it affects no more than 1 in 2,000 people.
It is estimated that there are six to ten thousand rare diseases. The trend is rising due to advanced diagnostics – which also applies to the number of people affected. The diseases can be genetic, infectious or environmental in nature. Many rare diseases begin in childhood, some develop later. They are often life-threatening or chronic and have a significant impact on the quality of life of those affected.
How many people are affected by rare diseases?
Each individual disease may be rare in itself, but rare diseases as a whole affect a significant number of people worldwide. As rare diseases are often unrecognized or misdiagnosed, it is very likely that the actual number of people affected is even higher. Furthermore, the impact of a rare disease affects not only the patients themselves, but also their families, caregivers and society as a whole, as these diseases are often associated with high levels of stress and special challenges.
Did you know, that...
How can research save lives of those suffering from rare diseases?
The vast majority of rare diseases are virtually unexplored, which is why treatment options are generally limited to the treatment of symptoms. Curative treatment approaches and specific drugs are absolute exceptions. These are also known as orphan drugs because they are intended for the proverbial “orphans of medicine.”
First hand account
However, the story of the Bopp family shows what research can achieve. Within the space of a few weeks, the previously bright three-year-old lost everything he had learned up to that point. A pediatrician discovered that Sebastian was suffering from a rare genetic defect and developed a successful therapy. It allows his sisters, who are also affected, to grow up without symptoms and gives Sebastian a piece of his old life back.
From rare to common – why do rare diseases affect us all?
Anyone who understands the mechanisms behind a rare disease can often deduce the causes of common conditions such as obesity, heart failure and bone diseases. Leading scientists are convinced that research into rare diseases will pave the way for the personalized precision medicine of tomorrow.
This is also reflected in the fact that modern diagnostics are increasingly defining subtypes of common diseases that are formally considered rare.
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationNewsletter Subscription
Our free newsletter informs you about current calls for proposals, events and projects concerning rare diseases.
Support the orphans of medicine!
ELHKS uses your donations in a targeted manner – so that medical progress reaches everyone.
-
Research
Stopping rapid ageing? Hope for children with a rare genetic defect
The Eva Luise Köhler Research Award has been presented annually since 2008 to promote research into rare diseases. The award money of €50,000 has already enabled more than a dozen…
-
Information & Opinion
A call for the preservation of human dignity – a stand against eugenic visions!
Statement of the Eva Luise and Horst Köhler Foundation for People with Rare Diseases on the Editorial of the Chairman of the KV Saxony Dr. Klaus Heckemann in the Bulletin…
-
Alliance4Rare
Clinician Scientist: Dr. Steffen Köhne, Universitätsmedizin Göttingen
The Alliance4Rare research network not only invests in research programs, but also in urgently needed young scientists through clinician/medical scientist programs. Read more about Dr. Nina-Maria Wilpert, Charité - Universitätsmedizin…